The effect of intravitreal injection of anti-VEGF drugs on the ophthalmotonus values in patients with classic and occult choroidal neovascularization

<br> Kuroyedov A.V.<sup>1,2</sup>, Zakharova M.A.<sup>3</sup>, Gaponko O.V.<sup>1</sup>, Gorodnichy V.V.<sup>1</sup><br> <br> <sup>1</sup> Central Military Clinical Hospital named after P. V. Mandryka, Moscow<br>...

Full description

Saved in:
Bibliographic Details
Main Authors: A.V. Kuroyedov, Zakharova M.A., O.V. Gapon’ko, V.V. Gorodnichiy
Format: Article
Language:Russian
Published: Prime-Media 2018-07-01
Series:РМЖ "Клиническая офтальмология"
Online Access:http://clinopht.com/upload/iblock/7b4/7b467e72ed1c1d901eaef66a83a5e862.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:<br> Kuroyedov A.V.<sup>1,2</sup>, Zakharova M.A.<sup>3</sup>, Gaponko O.V.<sup>1</sup>, Gorodnichy V.V.<sup>1</sup><br> <br> <sup>1</sup> Central Military Clinical Hospital named after P. V. Mandryka, Moscow<br> <sup>2</sup> Pirogov Russian National Research Medical University, Moscow<br> <sup>3</sup> S. Fyodorov Eye Microsurgery Federal State Institution, Moscow<br> <br> <b>Aim</b>: to study the changes in the level of intraocular pressure (IOP) in the early period after the intravitreal administration of anti-VEGF drugs in patients with classical and occult choroidal neovascularization (CNV).<br> <b>Patients and Methods:</b> 34 patients (40 eyes) with age-related macular degeneration were divided into 2 groups. Group 1 —&nbsp;the patients (19 eyes) with classic CNV, group 2 — the patients (21 eyes) with occult CNV. In all patients the IOP were measured an hour before the treatment, on the 7-th day after the injection of ranibizumab and at the 1-month follow-up visit.<br> <b>Results</b>: in group 1 the level of IOP increased an hour after the injection, but on the 7th day it was already at the initial level, which persisted after 1 month (p&gt;0,05). In the second group, the IOP level remained stable throughout the follow-up period&nbsp;<br> (p &lt;0.05). Differences in the level of IOP in an hour, on the 7th day and 1 month after intravitreal injection in patients of both groups and between groups were not detected (p&gt; 0.05). There was no significant difference in retinal thickness before and after intravitreal injection in both groups (p&gt; 0.05). However, significant difference was noted in patients of both groups in corrected visual acuity before and after treatment (p&lt;0.05).<br> <b>Conclusions</b>: in patients with a classical choroidal neovascularization, an increase in the IOP level was observed one hour after the intravitreal administration of anti-VEGF drugs. The difference in the IOP-level in patients with age-related macular degeneration in the group with classical CNV and in the group with occult CNV after intravitreal injection of the anti-VEGF was not detected in an hour, on the 7th day and 1 month after the administration of the anti-VEGF preparation.<br> <br> <b>Key words:</b> anti-VEGF drugs, IOP-level, choroidal neovascularization, age-related macular degeneration.<br> <b>For citation:</b> Kuroyedov A.V., Zakharova M.A., Gaponko O.V., Gorodnichy V.V. The effect of intravitreal injection of anti-VEGF drugs on the ophthalmotonus values in patients with classic and occult choroidal neovascularization.&nbsp;<br> RMJ “Clinical ophthalmology”. 2018;2:102–106.<br>
ISSN:2311-7729
2619-1571